4
Changes in Ownership
Krystal Biotech, Inc. Filed Acc 0001209191-19-061173
Chief Operating Officer sold 50,000 shares at an average $62.04 ($3,101,954)
From the SEC's structured data for this filing
Trades in this filing
Krishnan Suma · Chief Operating Officer
Table I: Non-derivative
14 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-12-16 | Sale : show line 1 in the form | −7,373 | $62.84 | $463,352 | 1,994,089 | D |
| 2019-12-16 | Sale : show line 2 in the form | −7,396 | $63.62 | $470,559 | 1,986,693 | D |
| 2019-12-16 | Sale : show line 3 in the form | −5,856 | $64.28 | $376,413 | 1,980,837 | D |
| 2019-12-16 | Sale : show line 4 in the form | −322 | $65.60 | $21,125 | 1,980,515 | D |
| 2019-12-17 | Sale : show line 5 in the form | −8,138 | $59.87 | $487,203 | 1,972,377 | D |
| 2019-12-17 | Sale : show line 6 in the form | −8,799 | $60.46 | $531,996 | 1,963,578 | D |
| 2019-12-17 | Sale : show line 7 in the form | −891 | $61.72 | $54,994 | 1,962,687 | D |
| 2019-12-17 | Sale : show line 8 in the form | −1,834 | $62.79 | $115,158 | 1,960,853 | D |
| Open-market sales · 50,000 sh · avg $62.04 · $3,101,954 | ||||||
Loading xslF345X03/doc4.xml…